Fast genetic data analysis
Israel’s Geneyx Genomex utilizes the world’s largest unified global knowledge base for interrogating genetic-based diseases and disorders. It provides fast analysis, interpretation, and reporting to help labs accelerate the development of targeted and personalized therapeutics.
Natural remedies for feminine ailments
Israel’s Algamed is using natural-based compounds made from algae plus its own innovative FemTech to treat sensitive feminine conditions. The algae excretes a gel that keeps it moist, and has numerous anti-bacterial, anti-inflammatory, antiviral, and anti-aging benefits.
Innovative eye treatment technology
Israel’s BioLight (see previously) is partnering with Tel Aviv’s Sourasky (Ichilov) Medical Center, to locate and develop innovative technologies in ophthalmology. Also, Biolight’s subsidiary Diagnostear has begun a clinical trial in India of its diagnosis of Dry Eye Disease.
Small molecules to treat ALS
Israel’s Neuromagen is developing a new class of small molecules to treat ALS (Amyotrophic Lateral Sclerosis - Lou Gehrig’s Disease), and other neurodegenerative diseases. The molecules activate the enzyme telomerase reverse transcriptase, which protects and rehabilitates neuronal cells.
Digitizing neurology
Israel’s NeuraLight uses video from smartphone or web camera, to catch neurological patterns and digital markers. Its computer vision and deep learning algorithms help accelerate development of therapies including Parkinson’s, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases.
Silencing tumor communications
Researchers at Israel’s Technion Institute have developed a breakthrough cancer treatment by injecting analgesic nanoparticles into the bloodstream. These anaesthetize the nerves inside the tumors, shutting down communications between them, thus inhibiting tumor growth and spread.
It’s never too late
A 102-year-old woman has become the first Israeli to undergo cryoablation (freezing) treatment for breast cancer developed by Israel’s IceCure (see previously). The usual surgical solution was not an option for her, as a previous heart catheterization meant that an operation was too risky.
Immunotherapy dose reduced by a million
The NanoGhost cancer treatment targeted delivery mechanism developed by scientists at Israel’s Technion Institute is truly revolutionary (see previously). It enables the dose of existing immunotherapies (e.g., TRAIL) to be reduced by a millionfold, to prevent toxic side effects.
Networking for patients
Israel’s Alike.Health connects patients with a similar medical condition at various stages of treatment or illness, allowing them to learn from each other about ways to cope. The startup has just been selected to join the “Google for Startups Accelerator”, Google’s 3-month mentoring program.
Keeping employees healthy
Israel’s Insurights has developed an AI platform to help employees utilize their health benefits. It answers questions, highlights preventive care benefits, and finds lower-cost providers. Its key feature is Zoe, a “Virtual Chief Health Officer,” who can analyze any insurer’s healthcare plan.